Can Mounjaro Cause Seizures? What the Clinical Evidence Actually Shows

You've read something worrying about Mounjaro and seizures — here's the real picture

Imagine you've just received your Mounjaro pen in its plain DPD box, you've tracked it to the door, and then you stumble across a forum post claiming the medicine can trigger seizures. It's the kind of thing that stops you in your tracks. So let's deal with it directly.

The UK prescribing information for tirzepatide (the document that lists every adverse event observed in clinical studies) does not include seizures. The NHS patient information for tirzepatide describes the side-effect profile in plain terms: it is dominated by gastrointestinal effects (nausea, vomiting, diarrhoea, constipation) along with headache, fatigue and dizziness. Seizures are not on that list. The SURMOUNT trial programme, which enrolled thousands of adults across its studies, did not surface seizure events as a drug-related finding.

What sometimes creates confusion is that tirzepatide does slow gastric emptying and can cause significant fluid loss through vomiting or diarrhoea, particularly in the early weeks of treatment or after a dose increase. Severe dehydration (from any cause) can disturb blood electrolytes in ways that, independently, may lower seizure threshold in vulnerable individuals. That is not the medicine causing a seizure; it is dehydration doing so. Staying well hydrated, especially during a bout of GI upset, matters on this treatment. If vomiting or diarrhoea is severe or prolonged, contact your prescriber or NHS 111 rather than waiting it out.

There is a broader question worth asking here too: if you are on anti-epileptic medication and considering Mounjaro, you should know that tirzepatide slows gastric emptying, which can affect how quickly other medicines are absorbed. Your prescriber needs to know about every medicine you take. This is a different concern from seizures being a direct effect of tirzepatide, but it is clinically relevant and worth raising. Some patients also ask whether Mounjaro could be linked to conditions such as deep vein thrombosis, and you can read about whether Mounjaro can cause DVT if that is something on your mind.

What Mounjaro actually does in the body, and why neurological side effects are a different category

Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, which regulate appetite, fullness and blood-sugar handling. Its effects are concentrated in the gut, the pancreas and appetite-signalling pathways. You can read a thorough overview of how Mounjaro works and what it is licensed for if you want the fuller picture. The central nervous system is not a primary target of the drug's mechanism in the same way that, say, a stimulant or an anticonvulsant would be.

The known neurological-adjacent side effects in clinical trials were headache and dizziness, both common GI-medicine effects and both listed clearly. Neither is a sign of central nervous system disruption in the way a seizure would be. No signal connecting tirzepatide to new-onset epilepsy or seizure disorder has appeared in post-marketing surveillance or the published trial data reviewed by the MHRA when granting UK authorisation. The medicine carries a Black Triangle designation, meaning any unexpected adverse events should be reported, but seizures have not emerged as a pattern.

It is also worth distinguishing tirzepatide's profile from concerns about other drug classes. Some glucose-lowering medicines can cause hypoglycaemia (low blood sugar), which in severe cases may trigger seizures. Tirzepatide, used without insulin or a sulfonylurea, has a very low hypoglycaemia risk in people without diabetes. If you are taking it alongside other diabetes medicines, discuss hypoglycaemia risk specifically with your prescriber, it remains a drug-interaction question, not a direct tirzepatide effect. You might also want to read about what Mounjaro can and cannot cause more broadly.

When to get medical help, and what to tell your prescriber

If you experience a seizure at any point while taking any medicine, including Mounjaro, seek urgent medical attention. A seizure is never something to observe and wait on. Emergency services or A&E are the right first call; your prescriber is the right second one for the follow-up conversation about whether to continue treatment.

Outside of an emergency, raise the following with a prescriber before starting tirzepatide: any personal history of seizures, epilepsy or conditions affecting the central nervous system; any anti-epileptic medicines you are currently taking; and any concerns about electrolyte balance or kidney function, because both affect seizure threshold independently. Patients sometimes also arrive wondering whether Mounjaro could be responsible for urinary symptoms, and if that applies to you, our page on whether Mounjaro can cause a UTI addresses that question directly.

The MHRA's Yellow Card scheme exists precisely for situations where a patient suspects a link between a medicine and an unexpected symptom. If you or your prescriber believe tirzepatide may have contributed to an adverse event, a Yellow Card report adds to the national safety dataset, that is how post-marketing surveillance works, and it is a meaningful contribution. Tirzepatide's Black Triangle status means this reporting is actively encouraged.

Questions about specific neurological conditions and tirzepatide compatibility are genuinely clinical questions, and if you have seen claims online about a possible connection to conditions like multiple sclerosis, you can find a considered answer on our page about whether Mounjaro can cause MS. Our clinical team reviews every consultation personally; the right place to raise complex medical history is there, not a forum. If you want to understand more about the medicine's known side-effect profile before your consultation, the gastrointestinal effects of tirzepatide are among the most commonly reported and worth reading about. For anything that feels outside routine, our support team is available seven days a week.

If you are at the point of thinking about starting treatment and want to understand what a clinical assessment involves, you can explore how a consultation with our prescribers works, at no cost, and reviewed the same day.